Any prior procedures (versus none)

1.242

1.113

1.385

0.0001

African-American (versus others)

1.158

1.048

1.28

0.0039

Duration of procedure (min)

1.004

1.001

1.007

0.0048

DVT prophylactic users (versus non users)

0.7609

0.6226

0.9298

0.0075

Current or recent smoker (versus not)

1.139

1.009

1.286

0.0351

Any prior medical therapy within 3 months (versus 'no')

1.107

1

1.226

0.0498

Comorbidities

1.133

0.9983

1.286

0.0531

Material used—embosphere (versus 'others')

1.618

1.297

2.02

Material used—embogold (versus 'others')

1.655

1.279

2.143

Material used—PVA (versus 'others')

1.189

0.9253

1.529

0.1214

Prophylactic antibiotics users (versus none)

0.8453

0.6659

1.073

0.1671

Size of fibroid

1.014

0.991

1.037

0.2383

No. of fibroids

0.9761

0.936

1.018

0.2602

Age

0.9932

0.9806

1.006

0.2962

Vessel embolized—UA bilateral (versus 'single')

1.241

0.8173

1.885

0.3107

Academic site (versus nonacademic)

0.7834

0.4837

1.269

0.321

Core site (versus participating site)

0.792

0.486

1.291

0.3492

Experience: 0-117 cases

2.268

1.531

3.359

Experience: 118-200 cases

2.558

1.751

3.738

Experience: 201-390 cases

2.087

1.308

3.332

Experience: 391-751 cases

1.708

1.412

2.067

0.3944

Presenting symptom—bulk symptoms (versus other)

0.8414

0.6317

1.121

Presenting symptom—heavy bleeding (versus other)

0.8928

0.6622

1.204

Presenting symptom—pelvic pain (versus other)

1

0.9999

1

0.5684

Fibroid morphology—submucosal versus others

1.049

0.8395

1.311

0.6729

Uterine volume (cc)

1

0.9999

1

0.8146

BMI

1.001

0.9886

1.014

0.8272

Parity (one or more versus none)

1.006

0.8686

1.166

0.9323

Fibroid location—lower uterine segment/cervix versus others

0.9876

0.7365

1.324

0.9337